References
Murakami H, Irisawa H, Saitoh T, Matsushima T, Tamura J, Sawamura M, Karasawa M, Hosomura Y, Kojima M (1997) Immunological abnormalities in splenic marginal zone cell lymphoma. Am J Hematol 56:173–178
Fodor A, Molnar MZ, Krenacs L, Bagdi E, Csomor J, Matolcsy A, Demeter J (2009) Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma. Pathol Oncol Res (in press)
Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis MC, Korkolopoulou P, Kontopidou FN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Tsaftaridis P, Plata E, Angelopoulou MK (2008) Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol 26:114
D’Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D’Arco AM, Cascavilla N (2007) Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. Eur J Haematol 79:53–58
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ, International Workshop on Chronic Lymphocytic Leukemia (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446–5456
Fabbri A, Gozzetti A, Lazzi S, Lenoci M, D’Amuri A, Leoncini L, Lauria F (2006) Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia. Clin Lymphoma Myeloma 6:496–499
Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Papadaki T, Remstein ED, Salar A, Solé F, Stamatopoulos K, Thieblemont C, Traverse-Glehen A, Wotherspoon A, Coiffier B, Piris MA (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22:487–495
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fozza, C., Galleu, A., Careddu, M.G. et al. Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma. Ann Hematol 89, 113–114 (2010). https://doi.org/10.1007/s00277-009-0782-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-009-0782-y